Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

2.9K
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
2.9K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

835
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
835
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

423
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
423
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

1.4K
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
1.4K
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

53
The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
53
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

1.3K
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to comment on "Extended-Spectrum Beta-Lactamase Positivity in Infants with Febrile Urinary Tract Infection: Risk Factors, Pathogen Distribution, and Temporal Trends".

Turkish archives of pediatrics·2026
Same author

White coat hypertension and left ventricle geometry in childhood.

Blood pressure·2025
Same author

A pilot single center study in children with enuresis; exploring frequency and charecteristics of monosymptomatic and non-monosymptomatic nocturnal enuresis.

BMC urology·2025
Same author

Reply to correspondence: functional immunity in hepatitis B: when titers don't tell the whole story.

European journal of pediatrics·2025

Related Experiment Video

Updated: Apr 29, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

7.8K

Extended-Spectrum Beta-Lactamase Positivity in Infants with Febrile Urinary Tract Infection: Risk Factors, Pathogen

Serap Ata1, Sevgi Akova2

  • 1Department of Pediatrics, Ümraniye Training and Research Hospital, University of Health Sciences, İstanbul, Türkiye.

Turkish Archives of Pediatrics
|April 27, 2026
PubMed
Summary

Urinary tract anomalies and prior antibiotic exposure increase the risk of extended-spectrum beta-lactamase (ESBL) producing bacteria in infants with febrile urinary tract infections (UTIs). Klebsiella pneumoniae is increasingly prevalent, necessitating a review of empirical antibiotic strategies.

Keywords:
EnterobacteriaceaeTürkiyeantimicrobial resistanceextended-spectrum beta-lactamaseinfantrisk factorsurinary tract infections

More Related Videos

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

1.7K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

5.5K

Related Experiment Videos

Last Updated: Apr 29, 2026

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice
08:53

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

7.8K
Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

1.7K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

5.5K

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Resistance
  • Clinical Microbiology

Background:

  • Febrile urinary tract infections (UTIs) in infants are a common concern.
  • Extended-spectrum beta-lactamase (ESBL) producing organisms pose a significant treatment challenge.
  • Understanding risk factors and trends is crucial for effective management.

Purpose of the Study:

  • Identify risk factors for ESBL positivity in infants with febrile UTI.
  • Compare pathogen distribution and antibiotic resistance based on ESBL status.
  • Analyze temporal trends in ESBL positivity and associated pathogens.

Main Methods:

  • Retrospective, single-center study of 321 infants (1-12 months) with first febrile UTI.
  • Comparison of ESBL-positive and ESBL-negative bacterial isolates.
  • Analysis of temporal trends in ESBL positivity, pathogens, and empirical antibiotic use.

Main Results:

  • Overall ESBL positivity rate was 57.3%.
  • Risk factors included urinary tract anomalies, recent antibiotic exposure, and prophylactic antibiotic use.
  • Klebsiella pneumoniae and Enterobacter cloacae were more frequent in ESBL-positive isolates, while Escherichia coli was less frequent.
  • Higher resistance rates to common antibiotics were observed in ESBL-positive isolates.
  • ESBL positivity peaked in 2023, with decreasing E. coli and increasing K. pneumoniae frequencies over time.

Conclusions:

  • Urinary tract anomalies and prior antibiotic exposure are key risk factors for ESBL-positive febrile UTI in infants.
  • The rising prevalence of K. pneumoniae and high resistance rates necessitate reassessment of empirical antibiotic strategies.
  • This highlights the need for vigilant monitoring and adaptive treatment approaches in pediatric populations.